Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Spertini F, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Haahtela T, Zuberbier T; MASK study group*. Bousquet J, et al. Among authors: mullol j. J Allergy Clin Immunol. 2016 Aug;138(2):367-374.e2. doi: 10.1016/j.jaci.2016.03.025. Epub 2016 Apr 23. J Allergy Clin Immunol. 2016. PMID: 27260321 Free article. Review.
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement.
Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, Bernal-Sprekelsen M, Canonica GW, Gevaert P, Joos G, Lund V, Muraro A, Onerci M, Zuberbier T, Pugin B, Seys SF, Bousquet J; ARIA and EPOS working groups. Hellings PW, et al. Allergy. 2017 Sep;72(9):1297-1305. doi: 10.1111/all.13162. Epub 2017 May 21. Allergy. 2017. PMID: 28306159 Free article.
Evaluating treatment response to mepolizumab in patients with severe CRSwNP.
Hopkins C, Han JK, Lund VJ, Bachert C, Fokkens WJ, Diamant Z, Mullol J, Sousa AR, Smith SG, Yang S, Mayer B, Yancey SW, Chan RH, Lee SE. Hopkins C, et al. Among authors: mullol j. Rhinology. 2023 Apr 1;61(2):108-117. doi: 10.4193/Rhin22.200. Rhinology. 2023. PMID: 36716382 Clinical Trial.
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.
Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, Scadding GK, Wagemann M, Bernal-Sprekelsen M, Chaker A, Heffler E, Han JK, Van Staeyen E, Hopkins C, Mullol J, Peters A, Reitsma S, Senior BA, Hellings PW. Fokkens WJ, et al. Among authors: mullol j. Rhinology. 2023 Jun 1;61(3):194-202. doi: 10.4193/Rhin22.489. Rhinology. 2023. PMID: 36999780
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care.
Hellings PW, Lau S, Scadding GK, Bjermer L, Backer V, Chaker AM, Conti DM, De Corso E, Diamant Z, Djukanovic R, Fokkens W, Gevaert P, Gray CL, Han JK, Heaney LG, Hoffmann HJ, Jesenak M, Johansen P, Kumaran MS, McDonald M, Melén E, Mullol J, Reitsma S, Ryan D, Scadding G, Schmid-Grendelmeier P, Teeling T, Odemyr M, Wahn U. Hellings PW, et al. Among authors: mullol j. Front Allergy. 2023 Jul 27;4:1236977. doi: 10.3389/falgy.2023.1236977. eCollection 2023. Front Allergy. 2023. PMID: 37577332 Free PMC article.
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, Chaker A, Diamant Z, Gevaert P, Han J, Hopkins C, Hox V, Klimek L, Lund VJ, Lee S, Luong A, Mullol J, Peters A, Pfaar O, Reitsma S, Toppila-Salmi S, Scadding GK, Sedaghat AR, Viskens AS, Wagenmann M, Hellings PW. Fokkens WJ, et al. Among authors: mullol j. Rhinology. 2024 Jan 13. doi: 10.4193/Rhin23.415. Online ahead of print. Rhinology. 2024. PMID: 38217529
Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World Experience.
Loli-Ausejo D, Perdomo G, Mascaró B, Martínez-Olondris P, Sánchez-Fernández MC, Mullol J, Valero A, Arismendi E, Bobolea I. Loli-Ausejo D, et al. Among authors: mullol j. J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):209-210. doi: 10.18176/jiaci.0898. Epub 2023 Feb 23. J Investig Allergol Clin Immunol. 2023. PMID: 36820628 Free article. No abstract available.
542 results